top of page

Declan O'Mahoney to Help Deliver Next Phase of Growth

Equal1, a silicon-based quantum computing company, today announced the appointment of Declan O’Mahoney as Non-Executive Chairman of its Board of Directors as of June 1, 2021. Mr. O’Mahoney is founder and principal of Maywentee, which advises tech companies to grow and deliver shareholder value.

“With the company’s strong team, intellectual property and investors, I see a tremendous opportunity with Equal1,” says Mr. O’Mahoney. “This is a world-class team with a disruptive approach to a deep tech challenge that will have an enormous effect on everyday quantum computing, with a substantial environmental impact. We’re poised and ready to execute our plan to deliver low-cost quantum computing solutions in the near term.

Mr. O’Mahoney brings extensive international experience in technology companies. He is entrepreneur in residence at the Tyndall National Institute and is board director, investor and/or advisor to several technology companies including VoxPro recently acquired by Telus International (NYSE:TU), Rockley Photonics (recently filed for IPO NYSE), SD WindEnergy Japan which acquired the wind energy division of Kingspan PLC., and TouchPress Inc. recently acquired by Team17 PLC.

Previously, he was Chief Executive Officer of HeartSine Inc. (2012-2016), a defibrillator company based in Belfast and Pennsylvania, which was acquired by Physio-Control, Inc. Redmond, Washington in October 2015 and subsequently acquired by Stryker Corporation (NYSE: SYK) in April 2016. Prior to HeartSine, he was CEO of Firecomms (2002-2011), a compound semiconductor company spinout from Ireland’s Tyndall National Institute that was acquired by ZJY Corp of Zhejiang.

Says board member Gerry McGuire of Atlantic Bridge Ventures, “We have worked with Declan from start-up to exit and we are delighted he has stepped into this role. Declan has experience working with deep tech teams to bring value for shareholders and is a great addition to the Equal1 team.”


bottom of page